Vaxxinity Correlations

VAXX Stock  USD 0.70  0.03  4.48%   
The correlation of Vaxxinity is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vaxxinity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vaxxinity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Average diversification

The correlation between Vaxxinity and NYA is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Vaxxinity and NYA in the same portfolio, assuming nothing else is changed.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxxinity. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy Vaxxinity Stock please use our How to Invest in Vaxxinity guide.
  
The ability to find closely correlated positions to Vaxxinity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vaxxinity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vaxxinity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vaxxinity to buy it.

Moving together with Vaxxinity Stock

  0.8VALN Valneva SE ADR Report 28th of March 2024 PairCorr
  0.76PFE Pfizer Inc Aggressive PushPairCorr
  0.62MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.7SLRX Salarius Pharmaceuticals Report 25th of March 2024 PairCorr
  0.63BGXX Bright Green Corp Report 16th of April 2024 PairCorr
  0.71CMND Clearmind Medicine CommonPairCorr

Moving against Vaxxinity Stock

  0.75MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.73ALVO Alvotech Report 6th of March 2024 PairCorr
  0.72LPCN Lipocine Report 8th of March 2024 PairCorr
  0.63AQST Aquestive Therapeutics Report 5th of March 2024 PairCorr
  0.61CPIX Cumberland Pharmaceuticals Report 5th of March 2024 PairCorr
  0.59JNJ Johnson Johnson Aggressive PushPairCorr
  0.52ESPR Esperion Therapeutics Earnings Call This WeekPairCorr
  0.51CDXS Codexis Earnings Call This WeekPairCorr
  0.73TFX Teleflex Incorporated Downward RallyPairCorr
  0.6JYNT Joint Corp Report 14th of March 2024 PairCorr

Related Correlations Analysis

EVVTY
DDI
WIGAF
MTSI
AINSF
EPGG
ON
EVVTY
0.470.00.170.670.00.56
EVVTY
DDI
0.470.0-0.320.330.0-0.06
DDI
WIGAF
0.00.00.00.0-1.00.0
WIGAF
MTSI
0.17-0.320.00.040.00.64
MTSI
AINSF
0.670.330.00.040.00.11
AINSF
EPGG
0.00.0-1.00.00.00.0
EPGG
ON
0.56-0.060.00.640.110.0
ON
EVVTY
DDI
WIGAF
MTSI
AINSF
EPGG
ON
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AINSFEVVTY
ONMTSI
ONEVVTY
DDIEVVTY
AINSFDDI
MTSIEVVTY
  
High negative correlations   
EPGGWIGAF
MTSIDDI
ONDDI
ONEPGG
EPGGAINSF
EPGGMTSI

Risk-Adjusted Indicators

There is a big difference between Vaxxinity Stock performing well and Vaxxinity Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vaxxinity's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Vaxxinity without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Correlation Analysis Now

   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Module

Vaxxinity Corporate Management

Elected by the shareholders, the Vaxxinity's board of directors comprises two types of representatives: Vaxxinity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vaxxinity. The board's role is to monitor Vaxxinity's management team and ensure that shareholders' interests are well served. Vaxxinity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vaxxinity's outside directors are responsible for providing unbiased perspectives on the board's policies.
Peter MDGlobal VPProfile
Louis IVCoFounder ChairmanProfile
Jon HarrisonChief OfficerProfile
Mei JDCEO DirectorProfile
Ulo MDChief OfficerProfile
Benjamin MatoneVP RelationsProfile
Mark JoinnidesChief StaffProfile

Already Invested in Vaxxinity?

The danger of trading Vaxxinity is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Vaxxinity is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Vaxxinity. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Vaxxinity is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Vaxxinity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vaxxinity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaxxinity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vaxxinity Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxxinity. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy Vaxxinity Stock please use our How to Invest in Vaxxinity guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Vaxxinity Stock analysis

When running Vaxxinity's price analysis, check to measure Vaxxinity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxxinity is operating at the current time. Most of Vaxxinity's value examination focuses on studying past and present price action to predict the probability of Vaxxinity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxxinity's price. Additionally, you may evaluate how the addition of Vaxxinity to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Is Vaxxinity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaxxinity. If investors know Vaxxinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaxxinity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.53)
Quarterly Revenue Growth
(0.57)
Return On Assets
(0.47)
Return On Equity
(1.27)
The market value of Vaxxinity is measured differently than its book value, which is the value of Vaxxinity that is recorded on the company's balance sheet. Investors also form their own opinion of Vaxxinity's value that differs from its market value or its book value, called intrinsic value, which is Vaxxinity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaxxinity's market value can be influenced by many factors that don't directly affect Vaxxinity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaxxinity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaxxinity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxxinity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.